Techdow Pharma Germany GmbH (TPG) is the German sales subsidiary of the Chinese group Shenzhen Techdow Pharmaceutical Co., Ltd., serving the German‑speaking market in Germany and Austria. The company's purpose is the distribution and trade of pharmaceutical products; TPG focuses on marketing and selling Inhixa® (an enoxaparin sodium biosimilar) in Germany, with production of the sold products taking place exclusively in China. Distribution and storage are outsourced to logistics providers such as SK Pharma Logistics GmbH (Germany) and IHCS Arzneimittel Vertriebs GmbH (Austria), through which the company supplies pharmaceutical wholesalers, pharmacies and hospitals. Key management metrics are revenue and EBIT/EBITDA; in fiscal year 2021 revenue amounted to 26,139 TEUR, EBITDA to 3,319 TEUR and EBIT to 3,311 TEUR.
Gegenstand des Unternehmens ist der Vertrieb und/oder der Handel von pharmazeutischen Produkten, insbesondere der Handel mit Arzneimitteln. Die Gesellschaft kann alle damit verbundenen Geschäftstätigkeiten ausüben, insbesondere Marketingaktivitäten, Transport, Lagerung und Verwahrung, Forschung.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 184119 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 184119 (as of 9 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 184119 (as of 9 October 2026)
Sign in to view detailed salary and cost trends.
